INTERNATIONAL PATENT: ELIXIRGEN THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS FOR EXPRESSION OF PROTEIN FROM SYNTHETIC MRNA DELIVERED BY INJECTION"

GENEVA, Oct. 15 -- ELIXIRGEN THERAPEUTICS, INC. (855 North Wolfe Street, Suite 624Baltimore, Maryland 21205) filed a patent application (PCT/US2025/023042) for "METHODS FOR EXPRESSION OF PROTEIN FROM SYNTHETIC MRNA DELIVERED BY INJECTION" on Apr 03, 2025. With publication no. WO/2025/212951, the details related to the patent application was published on Oct 09, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KO, Minoru S.H. (c/o Elixirgen Therapeutics, Inc.855 North Wolfe Street, Suite 624Baltimore, Maryland 21205)

Abstract: The present disclosure relates to use of an oligosaccharide or a g...